Crystalys Therapeutics has dosed the first patient with its once daily oral, URAT1 inhibitor dotinurad in its Phase II AMETHYST trial (NCT07535034), designed to assess dotinurad’s effectiveness in ...

Crystalys Therapeutics Inc. ('Crystalys' or 'the Company'), a clinical-stage biopharmaceutical company addressing the significant unmet medical needs of people living with gout, today announced that ...

Aarti Pharmalabs Ltd (BOM:543748) reported a 9% year-over-year increase in Q4 revenue, reaching Rs 580 crore. The Xanthine derivative segment achieved its highest-ever quarterly revenue, contributing ...

Track Aarti Pharmalabs share price today on NSE/BSE with real-time updates. Check stock performance, fundamentals, market cap, shareholding, financial reports, annual & quarterly results, and profit & ...

Detailed price information for Xortx Therapeutics Inc (XRTX-Q) from The Globe and Mail including charting and trades.

Detailed price information for Xortx Therapeutics Inc (XRTX-X) from The Globe and Mail including charting and trades.

Bee pollen may ease menopause symptoms and protect against prostate inflammation. Consuming bee pollen supplies your body with essential protein, vitamins, and minerals. Bee pollen may cause allergic ...

Background: Xanthine oxidase inhibitors (XOI) are commonly used as urate lowering therapy (ULT) for the treatment of gout. Allopurinol, the first-line treatment, demonstrates low response rate (< 40%) ...

Get article recommendations from ACS based on references in your Mendeley library. Pair your accounts.

Sun and colleagues identify CLEC12B as a natural killer (NK) cell inhibitory checkpoint that limits antitumor immunity. They also develop a nanobody to target CLEC12B, activating NK cell killing of ...

Customer stories Events & webinars Ebooks & reports Business insights GitHub Skills ...